<DOC>
	<DOC>NCT01129245</DOC>
	<brief_summary>The purpose of this study is to assess the effect that Celebrex (a COX-2 inhibitor and non-steroidal anti-inflammatory drug) has on ovulation.</brief_summary>
	<brief_title>The Effect of a Non-hormonal Cox-2 Inhibitor (Celebrex) on Ovulation</brief_title>
	<detailed_description />
	<mesh_term>Celecoxib</mesh_term>
	<mesh_term>Cyclooxygenase 2 Inhibitors</mesh_term>
	<criteria>Age 1835 Currently NOT using hormonal contraception Cycle length between 2634 days General good health (specifically no hx of: diabetes, cardiac problems, moderate/severe heart burn (GERD), obesity (BMI &gt; 30), hypertension (BP &gt; 130/80) Willing and able to agree to randomization and informed consent Willing and able to use a menstrual diary to chart bleeding Serum progesterone &gt; 3 ng/ml (from cycle day 1825) Willing and able to return to clinic for biweekly for blood tests and ultrasounds throughout cycles 2, 3 &amp; 5 Diabetes Cardiac disease Moderate to severe heart burn (or GERD) Obesity (BMI &gt; 30) Hypertension (BP &gt; 130/80) Allergy to NSAIDS Currently pregnant or trying to conceive Polycystic Ovarian Syndrome Use of hormonal contraception (participants can use barrier methods, spermicide, female or male sterilization, copper intrauterine device, abstinence, or have female partners</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Celebrex</keyword>
	<keyword>prostoglandin inhibitor</keyword>
	<keyword>ovulation</keyword>
	<keyword>emergency contraception</keyword>
</DOC>